Replies to post #256100 on Biotech Values

[dewophile]

I wouldn’t want them to go it alone. However a royalty company could take a flier for a stake in future sales I guess. Still I would rather see a large pharma drive development now. They have the peds trial to run and probably should move 323 along as well so that might be too much to bite off without significant resources and know how